Sage Therapeutics Inc. News
Biogen Beats on Third Quarter Earnings and Raises Guidance
Biogen posts third-quarter earnings that beat forecasts and also ups its full-year profit forecast amid strong expected demand for its Alzheimer's treatment drug.
Premarket Movers Tuesday: Sage Therapeutics, MicroStrategy
Stocks moving in premarket trading Tuesday include Sage Therapeutics, Freeport-McMoRan, MicroStrategy, ContextLogic and Fastenal.
Sage Therapeutics Plunges After Depression Drug-Trial Results
Sage Therapeutics shares plunge following disappointing test results for its depression drug Zuranolone that it is producing with drug giant Biogen.
Sage Falls as Some Patients Drop Out of Tremor Treatment Study
Nearly 40% of patients left a Sage Therapeutics study of a treatment for tremors due to side effects.
Sage Therapeutics Rises After Swing to Profit on Biogen Deal
Sage Therapeutics traded higher after the biopharma posted a fourth-quarter profit, benefiting from its collaboration with Biogen.
10 Worst Stocks in the Nasdaq on Thursday: Moderna Drops
The worst-performing stocks in the Nasdaq on Thursday included Moderna, eBay, and Zoom Video, among others.
7 Best Stocks in the Nasdaq on Wednesday: Splunk Rises
The best-performing stocks in the Nasdaq on Wednesday included Splunk, Expedia, and Fox Corporation, among others.
Sage Therapeutics Draws Negative Commentary on Biogen Deal
Sage shares fell as two analysts offered negative assessments of its agreement with Biogen to work together on Sage's depression drug.
Sage to Get $1.53 Billion From Biogen for Depression Drug Development
The companies will develop Sage’s zuranolone for major depressive disorder, postpartum depression and other psychiatric disorders.
Domino's Pizza, Expedia: Latest Upgrades and Downgrades
TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Domino's Pizza, Expedia, and Dave & Buster's.
Breaking News
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Apple Preparing For iPhone 14 Launch On September 7 - Report
Bloomberg reported late Wednesday that Apple is eyeing a September 7 launch date for its new iPhone 14 series.
Huge Las Vegas Strip Casino Project Moves Forward
Sin City looks set to welcome another massive resort/casino that's going to compete with industry leaders Caesars and MGM.
Kohl's Stock Slumps After Retailer Guts Full-Year Profit Forecast As Shoppers Feel Inflation Squeeze
“Second quarter results were impacted by a weakening macro environment, high inflation and dampened consumer spending, which especially pressured our middle-income customers," said CEO Michelle Gass.